跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
臺北醫學大學附設醫院
臺北醫學大學
網站
http://tmuh.tmu.edu.tw/
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(353)
專案
(209)
研究成果
(8898)
資料集
(220)
活動
(1)
指紋
查看啟用 臺北醫學大學附設醫院 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adverse Event
18%
Adverse Outcome
14%
Antioxidant
12%
Apoplexy
47%
Atrial Fibrillation
16%
Biological Marker
26%
Bipolar Disorder
16%
Bleeding
15%
Body Mass Index
19%
Brain Ischemia
12%
Breast Cancer
43%
Cancer
19%
Cancer Cell
33%
Cancer Growth
14%
Carcinogenesis
11%
Cardiovascular Disease
16%
Cardiovascular System
14%
Case-Control Study
17%
Cell Migration
10%
Cell Proliferation
12%
Chronic Kidney Disease
30%
Cohort Analysis
59%
Colorectal Cancer
24%
Combination Therapy
14%
Computer Assisted Tomography
21%
COVID-19
16%
Cross Sectional Study
17%
Diabetes
29%
Diabetes Mellitus
24%
Diagnosis
17%
Disease
58%
Drug Therapy
20%
End Stage Renal Disease
10%
Endothelial Cell
11%
Epidermal Growth Factor Receptor
13%
Gene Expression
14%
Hazard Ratio
35%
Health Care Cost
12%
Hemodialysis
12%
Hepatocellular Carcinoma
31%
Hyperoxia
13%
Implant
12%
In Vitro
43%
Infection
22%
Injury
33%
Intensive Care Unit
13%
Isotopes of Calcium
13%
Kidney Function
10%
Knee
13%
Logistic Regression Analysis
24%
Lung Cancer
18%
Magnetic Resonance Imaging
24%
Malignant Neoplasm
58%
Maturity Onset Diabetes of the Young
21%
Medicine
13%
Mesenchymal Stem Cell
14%
Meta-Analysis
75%
Metastatic Carcinoma
36%
Mortality Rate
11%
Mouth Squamous Cell Carcinoma
10%
Nasopharynx Carcinoma
13%
Neoplasm
77%
Network Meta-Analysis
13%
Non Small Cell Lung Cancer
16%
Observational Study
11%
Obstructive Sleep Apnea
11%
Odds Ratio
48%
Osteoarthritis
14%
Outpatient
11%
Overall Survival
19%
Oxidative Stress
17%
Pediatrics
18%
Platelet
16%
Prevalence
30%
Prognostic Factor
12%
Programmed Cell Death
23%
Proportional Hazards Model
15%
Prostate Cancer
13%
Protein Expression
10%
Quality of Life
16%
Radiation Therapy
28%
Randomized Controlled Trial
39%
Rectum Cancer
13%
Recurrent Disease
19%
Rehabilitation Engineering
12%
Retrospective Cohort Study
26%
Retrospective Study
15%
Sepsis
13%
Signal Transduction
17%
Supplementation
11%
Surgeon
13%
Surgery
24%
Survival Rate
15%
Symptom
34%
Systematic Review
65%
Traditional Chinese Medicine
11%
Traumatic Brain Injury
14%
Tumor Cell
10%
Tumor Necrosis Factor
11%
Upregulation
13%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
12%
Adenosine Triphosphate
13%
Adverse Event
22%
All Cause Mortality
10%
Alternative Complement Pathway C3 C5 Convertase
14%
Anti-Inflammatory Drug
29%
Antiinfective Agent
14%
Antioxidant
26%
Atrial Fibrillation
12%
Biological Marker
22%
Bipolar Disorder
16%
Brain Ischemia
14%
Breast Cancer
32%
Cancer Growth
19%
Carcinogenesis
15%
Cardiovascular Disease
17%
Case-Control Study
16%
Caspase 3
15%
Cell Viability
16%
Chemotherapy
24%
Chronic Kidney Failure
33%
Chronic Obstructive Lung Disease
11%
Cisplatin
12%
Clinical Trial
12%
Cohort Study
75%
Colon Cancer
16%
Colorectal Cancer
31%
Combination Therapy
18%
Comorbidity
15%
Cyclooxygenase 2
12%
Cytokine
22%
Cytotoxicity
18%
Diabetes Mellitus
26%
Disease
59%
End Stage Renal Disease
11%
Epidermal Growth Factor Receptor
26%
Fibrosis
9%
Gelatinase B
11%
Glioblastoma
17%
Heart Failure
11%
Heart Infarction
13%
Heme Oxygenase 1
9%
Hemodialysis
20%
IC50
14%
Inducible Nitric Oxide Synthase
10%
Infection
25%
Inflammation
49%
Injury
28%
Interleukin 1
9%
Interleukin 6
12%
Lipopolysaccharide
24%
Liver Cell Carcinoma
39%
Lung Adenocarcinoma
12%
Lung Cancer
25%
Malignant Neoplasm
100%
Metastasis
11%
microRNA
13%
Mitogen Activated Protein Kinase
21%
Mitogen Activated Protein Kinase 3
10%
Mortality Rate
10%
Mouse
75%
Mouse Model
15%
Mouth Cancer
10%
Mouth Squamous Cell Carcinoma
13%
Nanoparticle
12%
Neoplasm
71%
Nitric Oxide
17%
Non Insulin Dependent Diabetes Mellitus
14%
Non Small Cell Lung Cancer
26%
Nuclear Factor
17%
Osteoarthritis
16%
Overall Survival
15%
Parkinson's Disease
14%
Pharmacokinetics
12%
Phosphotransferase
17%
Placebo
11%
Polysaccharide
9%
Prevalence
28%
Prostate Cancer
21%
Protein Kinase C
10%
Protein P53
16%
Randomized Controlled Trial
27%
Rat Model
13%
Reactive Oxygen Metabolite
28%
Receptor
18%
Recurrent Disease
15%
Resveratrol
10%
Sepsis
16%
Sleep Disordered Breathing
13%
Statin (Protein)
10%
Survival Rate
9%
Symptom
16%
Syndrome
10%
Therapeutic Effect
9%
Traditional Chinese Medicine
12%
Traumatic Brain Injury
12%
Tumor Growth
16%
Tumor Necrosis Factor
22%
Vasculotropin
10%
Western Blot
22%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
8%
Androgen Receptor
6%
Angiogenesis
8%
Animal Model
5%
Anticancer
8%
Atrial Fibrillation
9%
Autophagy
10%
Blood Level
9%
Blood Pressure
5%
Body Mass
11%
Body Weight
7%
Bone Density
6%
Bone Regeneration
7%
Cancer Cell
70%
Cancer Stem Cell
7%
Carcinogenesis
19%
Cardiac Muscle Cell
8%
Case-Control Study
9%
Catenin
14%
Cell Cycle
7%
Cell Death
5%
Cell Growth
8%
Cell Invasion
7%
Cell Migration
14%
Cell Proliferation
22%
Cell Viability
7%
Chondrocyte
6%
Clinical Trial
6%
Cohort Study
35%
Colon
15%
Comorbidity
9%
Computer Model
8%
Cross Sectional Study
8%
Cytokine
6%
Cytotoxicity
7%
DNA Methylation
8%
down Regulation
14%
Drug Resistance
9%
Eicosanoid Receptor
12%
Enzyme
7%
Epidermal Growth Factor Receptor
20%
Estrogen Receptor
8%
Fibroblast
12%
Gene Expression
27%
Gene Expression Profiling
5%
Gene Mutation
6%
Genetic Divergence
6%
Genetics
11%
Genotyping
13%
Glucose Blood Level
8%
Glucose-Regulated Protein
8%
Hemodialysis
15%
Hyperglycemia
7%
Insulin Resistance
6%
Integrin
6%
Interleukin-1
6%
Kidney Function
6%
Kinase
10%
Lipid
6%
Lipopolysaccharide
6%
Low Drug Dose
6%
Macrophage
6%
Mesenchymal-Epithelial Transition
11%
Messenger RNA
21%
Metabolic Pathway
8%
Methylation
10%
MicroRNA
17%
Mitochondrion
7%
Mitogen-Activated Protein Kinase
9%
Mouse
36%
Mouse Model
7%
Multivariate Analysis
5%
Osteoblast
6%
Overall Survival
16%
Oxidative Stress
11%
P53
10%
Phosphotransferase
10%
Platelet
13%
Platelet-Rich Plasma
6%
Prevalence
15%
Promoter Region
12%
Protein Expression
12%
Protein Kinase C
6%
RNA
7%
Signal Transduction
20%
Single-Nucleotide Polymorphism
9%
Small Molecule
6%
STAT3
9%
Stem Cell
31%
Surface Property
11%
Survival Rate
9%
Thrombocyte Activation
6%
Thrombomodulin
7%
Transcription
6%
Transcription Factors
6%
Tumor Necrosis Factor
7%
Tumor Progression
12%
Upregulation
16%
Vascular Endothelial Growth Factor
6%
Western Blot
11%